circRNA basic information
circBase ID: hsa_circ_0066351
Name: hsa_circ_FLNB
Synonym: human circ_0066351 / circ_0066351
Host Gene: FLNB
Genomic location(hg19): chr3:58118534-58124256:+
Genomic location(hg38): chr3:58132807-58138529:+
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005575
MONDO name: colorectal cancer
Disease details: colorectal cancer / CRC
Disease DO ID:
5672, 9256
Disease MeSH ID:
-
Disease NCIt ID:
C4978
Disease ICD11 ID:
-
Disease OMIM ID:
114500
Species: Human
Species details: Homo sapiens
Tissue specimen:

CRC tissues; adjacent normal tissues

Cell lines:

LoVo; Caco2; HCT8; HCT116; SW480; SW620; FHC

In vivo animal model:

-

circRNA-disease information
Expression pattern:
DN
Associated gene: MIER3, NEURL1B, LITAF, PRKAA2, GNG12, CCNYL1, LIFR, SEMA6A, TGFBR3, PHLPP2, MAP1B, THRB, SLC20A1
Associated microRNA: miR-27a-3p, miR-379-5p
Biological function: inhibits CRC cells proliferation
Molecular mechanism: ceRNA network (miRNA sponge) involving miR-27a-3p and miR-379-5p regulating downstream mRNAs
Biological pathway or process:

proliferation (inhibits); ceRNA regulation (other)

Detected method:
Q
S
Validation methods:

circRNA-seq; RT-qPCR; RNase R Treatment; Sanger Sequencing; Transfection; CCK8; Colony Formation Assay; EdU Staining; Clinical Sample Validation; Survival Analysis; Bioinformatics Analysis

Clinical significance:

Downregulated in CRC and negatively associated with distant metastasis; higher expression indicates better survival/prognosis in CRC patients; potential prognostic and immunotherapeutic biomarker.

Description:

This study identified hsa_circ_0066351 (from FLNB) as significantly down-regulated in colorectal cancer tissues and cell lines. Functional assays showed it suppresses CRC cell proliferation. Bioinformatic ceRNA analysis proposed a hsa_circ_0066351-miR-27a-3p/miR-379-5p-mRNA network with prognostic and potential immunotherapy-related relevance.

Confidence score:

0.7713

Other information
Title:

Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer.

Journal: Frontiers in immunology
Published: 2022
PubMed ID: 36405685
Study type:

combined biological and clinical study

Data availability: GSE205643
Code availability: -